NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000564

Registered date:01/01/2007

Phase II trial of docetaxel and carboplatin in patients with stage IVb or recurrent nonsquamous cell carcinoma of uterine cervix

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiednonsquamous cell carcinoma of uterine cervix
Date of first enrollment2006/12/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Patients with stage IVb recurrent nonsquamous cell carcinoma of uterine cervix

Outcome(s)

Primary OutcomeEfficacy
Secondary OutcomeSafety, Overall survival

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderFemale
Include criteria
Exclude criteria1.Fever with over 38.0C 2.Infection or WBC>12,000/mm3 3.Severe complications 4.Neuropathy >Grade 2 5.Edema > Grade 2 6.Double cancer 7.Massive pleural effusion and ascites 8.Hypersensitivity reactions to docetaxel or carboplatin 9.Patients judged as exclusive case by the investigator

Related Information

Contact

public contact
Name Muneaki Shimada
Address 36-1 Nishimachi, Yonago Japan Japan 683-8504
Telephone 0859-38-6647
E-mail mshima12@med.tottori-u.ac.jp
Affiliation Tottori University Department of Obstetrics and Gynecology
scientific contact
Name Junzo Kigawa
Address 32-1 Noshiro-cho, Matsue, Shimame Japan
Telephone 0852-60-8000
E-mail mshima12@med.tottori-u.ac.jp
Affiliation Matsue city hospital Department of Obstetrics and Gynecology